ProfileGDS4459 / ENSG00000189144
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 17% 8% 25% 20% 12% 17% 15% 20% 25% 12% 35% 24% 14% 19% 22% 5% 19% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.1917
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.828
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.2325
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.4820
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.6212
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.0717
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.7315
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.0320
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.2925
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.5412
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.7735
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.1724
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.6914
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.3919
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.0722
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.565
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.3219